Download the full white paper to learn how effective owner-side leadership can improve both project performance and organizational capacity.

Life sciences capital projects bring together architects, engineers, construction managers, contractors, and validation partners, each responsible for delivering their scope of work. Yet one responsibility extends across every phase of the project. Representing the owner’s interests.

That role has never been more important. In fact, 95% of life sciences capital projects fail to meet their authorized cost and/or schedule, highlighting the need for stronger oversight, clearer accountability, and more informed decision-making throughout the project lifecycle.

An Owner’s Project Manager (OPM) serves as the owner’s advocate, providing independent oversight that helps align stakeholders, manage risk, and keep decisions focused on the organization’s business and operational objectives. Rather than replacing design or construction partners, an OPM complements them by helping ensure facilities are designed not only to meet project objectives, but to support the reliable manufacture of therapies long after construction is complete.

The impact extends beyond reducing risk. Organizations with strong internal project delivery capabilities report 15% to 30% greater project throughput, demonstrating how effective owner-side leadership can improve both project performance and organizational capacity.

Read The Owner’s Project Manager Advantage to learn more.